VNO
60
10
BK
74
2
MCD
52
2
KLAC
47
4
PSX
47
2
ROP
62
3
DVN
21
3
BMY
60
2
HBI
59
4
DHI
48
4
LH
43
-2
GT
62
6
SIG
52
3
MAS
58
2
SE
61
-4
AON
54
2
UNP
52
7
TXT
55
3
EQT
57
-2
CL
58
2
VNO
60
10
BK
74
2
MCD
52
2
KLAC
47
4
PSX
47
2
ROP
62
3
DVN
21
3
BMY
60
2
HBI
59
4
DHI
48
4
LH
43
-2
GT
62
6
SIG
52
3
MAS
58
2
SE
61
-4
AON
54
2
UNP
52
7
TXT
55
3
EQT
57
-2
CL
58
2
Financhill
Back

ClearPoint Neuro Vs. Perspective Therapeutics Industry Stock Comparison

Sell
22

CLPT
ClearPoint Neuro

Last Price:
11.83
Seasonality Move:
9.94%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.49
Seasonality Move:
34.33%
Sell
22
ClearPoint Neuro (CLPT) is a Sell

Is ClearPoint Neuro a Buy, Sell or Hold?

  • The current ClearPoint Neuro [CLPT] share price is $11.84. The Score for CLPT is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • CLPT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.47. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CLPT Stock Price Chart

What is ClearPoint Neuro's stock price today?

  • The ClearPoint Neuro share price today is $11.84
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

CLPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.29 Sell
Relative Strength Index (14 RSI): 50.85 Buy
Chaikin Money Flow: 308607 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.23 - 13.05) Sell
Bollinger Bands (100): (8.3 - 12.84) Buy

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.06 Sell
Relative Strength Index (14 RSI): 14.31 Sell
Chaikin Money Flow: 5909257 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.39 - 12.93) Sell
Bollinger Bands (100): (10.25 - 14.79) Sell

CLPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.09 Buy
20-day SMA: 11.98 Sell
50-day SMA: 11.92 Sell
200-day SMA: 8.37 Buy
8-day EMA: 11.33 Buy
20-day EMA: 11.67 Buy
50-day EMA: 11.6 Buy
200-day EMA: 9.29 Buy

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.64 Sell
20-day SMA: 9.7 Sell
50-day SMA: 11.58 Sell
200-day SMA: 12.72 Sell
8-day EMA: 6.25 Sell
20-day EMA: 8.74 Sell
50-day EMA: 10.88 Sell
200-day EMA: 11.36 Sell

ClearPoint Neuro Earnings Growth & CLPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.24 per share, and an increase next year of $0.09 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

ClearPoint Neuro Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):